US 10105341
Treatment for obesity
granted A61KA61K31/27A61K9/0053
Quick answer
US patent 10105341 (Treatment for obesity) held by Jazz Pharmaceuticals International III Limited expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jazz Pharmaceuticals International III Limited
- Grant date
- Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/27, A61K9/0053, A61K9/48, A61P